These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 22466

  • 1. [The renin-aldosterone system in essential hypertension--hypotensive action of beta adrenergic blocking agents and variation of the renin-aldosterone system (author's transl)].
    Hata S.
    Nihon Naibunpi Gakkai Zasshi; 1977 Oct 20; 53(10):1129-39. PubMed ID: 22466
    [Abstract] [Full Text] [Related]

  • 2. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
    Stumpe KO, Vetter H, Hessenbruch V, Düsing R, Kolloch R, Krück F.
    Klin Wochenschr; 1975 Oct 01; 53(19):907-11. PubMed ID: 241876
    [Abstract] [Full Text] [Related]

  • 3. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F, Davison AM.
    Clin Nephrol; 1986 Mar 01; 25(3):149-54. PubMed ID: 2869848
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
    Salvetti A, Pedrinelli R, Simonini N.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov 01; 20(11):538-42. PubMed ID: 6757151
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA, Griffin TP, O'Shea PM, Dennedy MC.
    Clin Endocrinol (Oxf); 2016 Mar 01; 84(3):325-31. PubMed ID: 26300226
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone].
    Grüninger U, Akert R, Hunkeler H, Wegmüller E, Weidmann P, Hodler J.
    Klin Wochenschr; 1979 Jul 15; 57(14):731-9. PubMed ID: 470335
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.
    Rotmensch HH, Rocci ML, Vlasses PH, Swanson BN, Fedder IL, Soyka L, Ferguson RK.
    Am J Cardiol; 1984 Aug 01; 54(3):353-6. PubMed ID: 6147080
    [Abstract] [Full Text] [Related]

  • 15. Effects of carvedilol on renal function.
    Dupont AG.
    Eur J Clin Pharmacol; 1990 Aug 01; 38 Suppl 2():S96-100. PubMed ID: 1974513
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)].
    Lombardo M, Fusco M, Valente D.
    G Ital Cardiol; 1979 Aug 01; 9(12):1363-70. PubMed ID: 45015
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].
    Weidmann P, Beretta-Piccoli C, Ziegler W, Hirsch D, de Châtel RD, Reubi FC.
    Klin Wochenschr; 1976 Aug 15; 54(16):765-73. PubMed ID: 8663
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.